Champions Oncology (CSBR) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $12.6 million.
- Champions Oncology's Receivables - Net rose 923.33% to $12.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $12.6 million, marking a year-over-year increase of 923.33%. This contributed to the annual value of $11.2 million for FY2025, which is 348.2% up from last year.
- Latest data reveals that Champions Oncology reported Receivables - Net of $12.6 million as of Q4 2025, which was up 923.33% from $9.5 million recorded in Q3 2025.
- Champions Oncology's Receivables - Net's 5-year high stood at $16.8 million during Q1 2025, with a 5-year trough of $6.5 million in Q1 2021.
- Over the past 5 years, Champions Oncology's median Receivables - Net value was $9.0 million (recorded in 2022), while the average stood at $9.4 million.
- In the last 5 years, Champions Oncology's Receivables - Net plummeted by 1578.89% in 2023 and then skyrocketed by 11232.43% in 2025.
- Over the past 5 years, Champions Oncology's Receivables - Net (Quarter) stood at $8.2 million in 2021, then rose by 9.89% to $9.0 million in 2022, then dropped by 14.44% to $7.7 million in 2023, then soared by 49.23% to $11.5 million in 2024, then grew by 9.23% to $12.6 million in 2025.
- Its last three reported values are $12.6 million in Q4 2025, $9.5 million for Q3 2025, and $11.2 million during Q2 2025.